pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
nivolumab biosimilar
Bladder Cancer
Xbrane Biopharma AB
0
catalysts
Marketed
nizatidine
Nizatidine (nizatidine)
Acid Indigestion (Heartburn/Pyrosis)
Epic Pharma LLC
0
catalysts
Phase 3
nizubaglustat
nizubaglustat [INN]
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Azafaros BV
0
catalysts
Phase 3
← prev
page 200 of 231
next →
131
Pain
89
Neurology
1
nofazinlimab
nofazinlimab [INN]
Hepatocellular Carcinoma
CStone Pharmaceuticals Co Ltd
0
catalysts
pre_registration
nogapendekin alfa
Anktiva (nogapendekin alfa)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$IBRX
ImmunityBio, Inc.
0
catalysts
Phase 2
nomlabofusp
Friedreich Ataxia
$LRMR
Larimar Therapeutics, Inc.
0
catalysts
Phase 3
norelgestromin
Female Contraception
Progesterone receptor
$VTRS
Viatris Inc
0
catalysts
Marketed
norethindrone
Norethindrone (norethindrone)
Female Contraception
Naari USA Inc
0
catalysts
Marketed
norgestrel
Opill (norgestrel)
Female Contraception
HRA Pharma LLC
0
catalysts
Phase 1
norovirus [strain GI.1] vaccine
Norovirus Infections
$VXRT
Vaxart, Inc.
0
catalysts
Marketed
north american coral snake [Micrurus fulvius] antivenom [equine]
Antivenin (Micrurus fulvius)
Poisoning
$PFE
PFIZER INC
0
catalysts
Marketed
nortriptyline hydrochloride
Nortriptyline Hydrochloride (nortriptyline hydrochloride)
Depression
PAI Holding Co LLC
0
catalysts
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
0
catalysts
Phase 2
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
0
catalysts
Marketed
nusinersen
Spinraza (nusinersen)
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
0
catalysts
Phase 2
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
0
catalysts
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
0
catalysts
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
0
catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTL
Autolus Therapeutics plc
0
catalysts
Phase 3
obefazimod
Ulcerative Colitis
Cap binding complex
Abivax SA
0
catalysts
Phase 1
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
0
catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19
Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIO
Zenas BioPharma, Inc.
0
catalysts
Phase 3
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0
catalysts
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
0
catalysts
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
0
catalysts
Phase 3
obudanersen sodium
Angelman Syndrome
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
0
catalysts
Marketed
ocrelizumab
Ocrevus (ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Genentech Inc
0
catalysts
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
0
catalysts
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Somatostatin receptor
Camurus AB
0
catalysts